Bliss GVS Pharma Ltd – Channel Top Revisited Amid Bearish RSI Divergence

📍 Price Structure The stock remains confined within a rising parallel channel, now testing the upper boundary near ₹182. Volume has surged notably in recent weeks, signaling heightened market activity near this critical resistance. 📉 Bearish Divergence While price made a higher high, RSI has not confirmed the same, forming a bearish divergence — a potential sign of slowing momentum even as price approaches the upper end of the range. 🔍 Volume Context Rising volume into resistance often points to distribution or speculative buying. A breakout above the channel with strong follow-through would negate the divergence, but failure to sustain could lead to pullback toward the midline of the channel. 💡 Watch Levels Immediate resistance: ₹182–185 (channel top) Support zones: ₹160 and ₹140 (channel mid and lower bounds) 📢 Disclaimer: For educational and technical analysis purposes only; not investment advice. 👤 Rajneesh Sharma – SEBI Registered Research Analyst (INH000020332)